Riccardo Muscariello

Dr. Riccardo Muscariello


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
DRDomenico Rendina
Domenico Rendina
LDLanfranco D'elia
Lanfranco D'elia
VAVeronica Abate
Veronica Abate
ARAndrea Rebellato
Andrea Rebellato
IBIlaria Buondonno
Ilaria Buondonno
Raffaella FaraonioRaffaella Faraonio
Raffaella Faraonio
The vitamin D and microRNA (miR) systems may play a role in the pathogenesis of cardiometabolic disorders, including hypertension. The HYPODD study was a double-blind placebo-controlled trial aiming to assess the effects of cholecalciferol treatment in patients with well-controlled hypertension and hypovitaminosis D (25OHD levels < 50 nmol/L). In addition to this clinical trial, we also evaluated the effects of cholecalciferol and calcitriol treatment on miR-21 expression in vivo and in vitro, respectively. Changes in the cardiovascular risk profiles were evaluated in HYPODD patients treated with cholecalciferol (C-cohort) or with placebo (P-cohort). The miR-21circulating levels were measured in four C-cohort patients and five P-cohort patients. In vitro, the miR-21 levels were measured in HEK-293 cells treated with calcitriol or with ethanol vehicle control. Cholecalciferol treatment increased 25OHD levels and reduced parathormone, total cholesterol, and low-density lipoprotein cholesterol levels in C-cohort patients, whereas no significant changes in these parameters were observed in P-cohort patients. The miR-21 circulating levels did not change in the C- or the P-cohort patients upon treatment. Calcitriol treatment did not affect miR-21 levels in HEK-293 cells. In conclusion, hypovitaminosis D correction ameliorated the cardiovascular risk profiles in hypertensive patients treated with cholecalciferol but did not influence the miR-21 expression.

1 January 2021 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
RMRiccardo Muscariello
Riccardo Muscariello
DRDomenico Rendina
Domenico Rendina
RGRaffaele Giannettino
Raffaele Giannettino
SISerena Ippolito
Serena Ippolito
OROrnella Romano
Ornella Romano
SSSalvatore Scognamiglio
Salvatore Scognamiglio

25 August 2014 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
DRDomenico Rendina
Domenico Rendina
DPDaniela De Palma
Daniela De Palma
GFGianpaolo De Filippo
Gianpaolo De Filippo
FPF. De Pascale
F. De Pascale
RMRiccardo Muscariello
Riccardo Muscariello
FGFerruccio Galletti
Ferruccio Galletti
Simple nodular goiter and Hashimoto’s thyroiditis are 2 frequent nonmalignant thyroid diseases. Tobacco smoking has detrimental effects on the endocrine system and in particular on thyroid function and morphology. The objective of this cross-sectional study, involving 1800 Caucasian adults from a geographical area with mild iodine deficiency, was to evaluate the relationship between tobacco smoking, smoking cessation, and the prevalence of simple nodular goiter and Hashimoto’s thyroiditis. Thyroid status was evaluated by ultrasonic exploration of the neck, measurement of FT3, FT4, TSH, antibodies against thyroid peroxidase and thyroglobulin, and urinary iodine excretion. The fine-needle aspiration biopsy of significant nodules was also performed. Smoking habits were evaluated by a specific questionnaire and the calculation of number of pack years. Both current and previous smokers showed an increased risk of simple nodular goiter compared to never smokers after adjustment for potential confounders and known goitrogen factors. Interestingly, the simple nodular goiter risk was similar for never smokers and for previous smokers declaring a time since cessation of smoking for more than 69 months. Smoking habit was not associated to an increased risk of Hashimoto’s thyroiditis. Smoking appears to be an independent risk factor for simple nodular goiter but not for Hashimoto’s thyroiditis in an area with mild iodine deficiency. A prolonged withdrawal of smoking dramatically reduces the risk of simple nodular goiter occurrence. * These authors contributed equally to the study.

9 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
VAVeronica Abate
Veronica Abate
AVAnita Vergatti
Anita Vergatti
PIPaola Iaccarino Idelson
Paola Iaccarino Idelson
CRCostantino Recano
Costantino Recano
MBMarzia Brancaccio
Marzia Brancaccio
LDLanfranco D'elia
Lanfranco D'elia
Unhealthy dietary habits play a key role in the pathogenesis of nephrolithiasis (NL). The aims of this case–control study were to evaluate (i) the adherence to the Mediterranean Diet (MD) and the dietary salt intake in stone-forming patients (SF), (ii) the relationship occurring between MD adherence, salt intake and NL-related metabolic risk factors in SF, and (iii) the impact of combined high MD adherence and low salt intake on NL susceptibility. From 1 January 2018 to 31 December 2019, we recruited all SF consecutively referred to the Extracorporeal Shock Wave Lithotripsy (ESWL) center of Federico II University, and at least two control subjects without a personal history of NL, age-, sex-, and body mass index-matched to SF (NSF). All study participants were interviewed using the validated MEDI-LITE and MINISAL questionnaires. In an SF subgroup, the NL-related metabolic risk factors were also evaluated. SF showed a lower MD adherence and a higher salt intake compared with NSF. The NL susceptibility decreased by 36% [OR: 0.64 (0.59–0.70); p < 0.01] for each point of increase in MEDI-LITE score, while it increased by 13% [OR: 1.13 (1.03–1.25); p = 0.01] for each point of increase in MINISAL score. The SF prevalence was higher among subjects showing combined low MD adherence and high salt intake. In SF, the MEDI-LITE score directly correlated with 24 h-citraturia, whereas the MINISAL score directly correlated with urinary sodium and uric acid excretion. In conclusion, high MD adherence and low salt intake are associated with a reduced NL susceptibility, both separately and in combination.

5 July 2023 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
VAVeronica Abate
Veronica Abate
AVAnita Vergatti
Anita Vergatti
ACAniello Casoria
Aniello Casoria
AZAquilino Flavio Zarrella
Aquilino Flavio Zarrella
RMRiccardo Muscariello
Riccardo Muscariello
ATAntonella Tufano
Antonella Tufano
Venous thromboembolism (VTE) and major bleeding (MB) are life-threatening complications described in COVID-19 hospitalized patients and they can be considered as two sides of the same coin. This retrospective study aims to evaluate the risk factors for VTE and MB in COVID-19 patients admitted to two Italian hospitals. The medical records of all COVID-19 patients (males 139; 62.3%, mean age 67.2±13.6 years, body weight 88.2±20.6 kg) hospitalized from March 11th to July 31st, 2020 to the Federico II University Hospital and to Sea Hospital, Naples, Italy, were analyzed. The COVID-19 patients were classified into four groups: COVID-19 patients developing VTE and/or MB, COVID-19 patients developing only VTE, COVID-19 patients developing only MB, and COVID-19 patients not developing neither VTE nor MB. During the hospitalization, 53 COVID-19 patients (24.7%; males 40; 75.5%, mean age 67.2±13.6 years, weight 88.2±20.6 kg) developed VTE, 33 COVID-19 patients (15.3 %; males 17; 51.5, mean age 67.3±14.9 years, weight 74.1±14.3 kg) developed MB, and 129 COVID-19 patients not developed neither TVP nor MB. No parameters to identify severe COVID-19 complicated by VTE and/or MB were found. However, some clinical and biochemical parameters can be evaluated to predict the risk of MB in order to modify the treatment and take prompt action to reduce mortality.

1 September 2016 in European Urology Supplements
Verified
Journal Article
Closed access
SPS. Perdona
S. Perdona
CIC. Imbimbo
C. Imbimbo
GQG. Quarto
G. Quarto
DSD. Sorrentino
D. Sorrentino
RMRiccardo Muscariello
Riccardo Muscariello
VMV. Mirone
V. Mirone